Anti-Inflammation and Anti-Oxidation: The Key to Unlocking the Cardiovascular Potential of SGLT2 Inhibitors and GLP1 Receptor Agonists

Type 2 diabetes mellitus (T2DM) is a prevalent and complex metabolic disorder associated with various complications, including cardiovascular diseases. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP1-RA) have emerged as novel therapeutic agents...

Descrición completa

Detalles Bibliográficos

Principais autores:	Veronika A. Myasoedova, Michele Bozzi, Vincenza Valerio, Donato Moschetta, Ilaria Massaiu, Valentina Rusconi, Daniele Di Napoli, Michele Ciccarelli, Valentina Parisi, Piergiuseppe Agostoni, Stefano Genovese, Paolo Poggio
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2023-12-01
Series:	Antioxidants
Assuntos:	sodium-glucose cotransporter 2 inhibitors glucagon-like peptide 1 receptor agonists cardio-metabolism oxidative stress inflammation fibrosis
Acceso en liña:	https://www.mdpi.com/2076-3921/13/1/16
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!